Business Context and Reporting Period
This Form 8-K is filed by Parker-Hannifin Corporation (PH) on August 13, 2026. The report details the completion of a major acquisition and the associated financing activities executed on the same date.
Key Financial Metrics and Transactions
- Acquisition: Completed the merger with Filtration Group Corporation.
- Purchase Price: $9.25 billion in cash (cash-free, debt-free basis), subject to net working capital adjustments.
- Debt Financing: Borrowed a total of $7.75 billion to fund the transaction:
- $5.25 billion under a 364-Day Term Loan Facility.
- $2.50 billion under a Three-Year Term Loan Facility.
- Liquidity Impact: The filing does not provide specific post-transaction cash balances or liquidity ratios.
Material Changes Versus Prior Period
The primary material change is the addition of Filtration Group to Parker's consolidated operations and the immediate increase in debt obligations by $7.75 billion. No comparative financial performance metrics (revenue, profit, margins) for the current period versus the prior period are provided in this specific filing.
Guidance, Outlook, and Risks
This filing does not contain updated financial guidance, management outlook, or specific risk factors beyond the standard disclosure that the summary of the Merger Agreement is qualified by the full text of the agreement. The transaction was executed on a cash-free, debt-free basis, implying the assumption of no existing debt from the target company.
Investor Verification Checklist
- Verify the final purchase price after the net working capital adjustment.
- Review the full text of the Merger Agreement (Exhibit 2.1) for covenants and conditions.
- Examine the 364-Day and Three-Year Term Loan Agreements (Exhibits 10.1 and 10.2) for interest rates, repayment schedules, and financial covenants.
- Assess the impact of the $7.75 billion new debt on the company's leverage ratios and interest coverage.
- Monitor future filings for the integration progress of Filtration Group and any related goodwill impairment tests.